ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2349

Early Sympathectomy Inhibits Egress of Lymphocytes in Control and Arthritic Animals and Ameliorates Arthritic Disease

Susanne Klatt1 and Rainer Straub2, 1Internal Medicine I, University Hospital Regensburg, Regensburg, Germany, 2Internal Medicine, University Hospital Regensburg, Regensburg, Germany

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Adhesion molecules, animal models and catecholamines

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose: The sympathetic nervous system (SNS) plays an important role in course and development of autoimmune diseases like arthritis. In type II collagen- induced arthritis (CIA), early activation of the SNS is proinflammatory, but the SNS is anti-inflammatory in later stages of disease. Early sympathectomy (SYX) prior to immunization ameliorates disease severity, but beneficial mechanisms of early SYX are not completely understood. The aim of this study was to determine how the SNS influences energy expenditure in lymph nodes / spleen and, in parallel, egress of lymphocytes from draining lymph nodes / spleen of control and arthritic animals.

Methods: A new technique termed “spatial energy expenditure configuration (SEEC)” was developed to demonstrate bodily areas of high energy demand. SEEC is based on removal of tissue during the course of arthritis in DBA/1 mice, and subsequent determination of oxygen consumption in vitro as a measure of local energy expenditure (immune cell activation). SEEC was applied to healthy control animals, arthritic animals, and animals that underwent early SYX. We evaluated homing behaviour of labelled donor splenocytes, expression of CCR7 on lymphocytes by flow cytometry, concentration of CCL21 in lymphocyte cell culture supernatants, and levels of sphingosine-1-phosphate (S1P) in serum of arthritic, sympathectomized arthritic, and control animals.

Results: In draining lymph nodes and spleens of arthritic mice, we observed a marked increase in oxygen consumption and organ weight during the course of arthritis. Although early SYX ameliorated later CIA, early SYX increased energy consumption and cell numbers in arthritic but also in control lymph nodes. This was interpreted as a probable sign of lymphocyte retention in lymphoid organs in healthy and arthritic animals. Splenocyte migration to the spleen was enhanced in early SYX compared to control mice. After early SYX, we observed an elevated expression of CCR7 on lymph node cells and a higher level of CCL21 in lymphocyte cell culture supernatants. This probably contributes to retention of T cells and dendritic cells within lymph nodes. Egress of lymphocytes requires an S1P gradient, low in the lymph node parenchyma and high at the exit site in the vascular lumen. The measurement of S1P in mouse serum revealed a significant higher concentration in CIA animals when compared to controls. Importantly, early SYX decreased S1P concentration in arthritic animals to control levels.

Conclusion: By using the SEEC technique, we identified draining lymph nodes as target organs of the sympathetic nervous system. SYX-induced disease amelioration is probably exerted by sequestration of lymphocytes in secondary lymphoid organs. This might prevent recirculation of immune cells to peripheral sites of inflammation.

 

 


Disclosure:

S. Klatt,
None;

R. Straub,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/early-sympathectomy-inhibits-egress-of-lymphocytes-in-control-and-arthritic-animals-and-ameliorates-arthritic-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology